Psyched: LSD For Major Depression, Canada's Large Scale Psilocybin Macrodose Trial, Treatments For Autism Spectrum Disorder And Multiple Sclerosis And More
Psyched: LSD For Major Depression, Canada's Large Scale Psilocybin Macrodose Trial, Treatments For Autism Spectrum Disorder And Multiple Sclerosis And More
Psyched：用於重度抑鬱症的迷幻藥、加拿大大規模的 psilocybin 大劑量試驗、自閉症譜系障礙和多發性硬化症的治療方法等等
LSD Trial Study Shows Potential For Major Depression
LSD 試驗研究顯示可能出現重度抑鬱症
Psychedelics biopharma company Mind Medicine Inc. (NASDAQ:MNMD) recently shared positive topline data from an advanced clinical trial of LSD as a treatment of Major Depressive Disorder (MDD).
The double-blind Phase 2 study demonstrated "significant, rapid, durable and beneficial effects" on the mitigation of MDD symptoms. Read more HERE.
迷幻藥生物製藥公司 MindMedicine Inc 納斯達克股票代碼：MNMD）最近分享了來自迷幻藥高級臨牀試驗的積極頭條數據 作爲重度抑鬱症（MDD）的治療方法。
雙盲2期研究表明，對緩解MDD症狀有 “顯著、快速、持久和有益的作用”。 在這裏閱讀更多。
Canada's Large Scale Psilocybin Macrodose Trial
加拿大大規模的 psilocybin 大劑量試驗
Canadian biopharma company Apex Labs Ltd., has received Health Canada's approval for a comprehensive, "statistically powered" macro-and-multi dose advanced psilocybin trial on 160 patients.
The trial's primary indication (severe depression within PTSD) is...
加拿大生物製藥公司 Apex Labs Ltd. 已獲得加拿大衛生部的批...
登入免費觀看全文
登入/註冊